D. E. Shaw & Co., Inc. Bolt Biotherapeutics, Inc. Transaction History

D. E. Shaw & Co., Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.41 - $2.91 $368 - $759	-261 Reduced 0.71%	36,426 $74,000
Q1 2022 May 16, 2022	SELL	$2.74 - $4.82 $53,950 - $94,905	-19,690 Reduced 34.93%	36,687 $101,000
Q4 2021 Feb 14, 2022	SELL	$4.19 - $13.97 $38,233 - $127,476	-9,125 Reduced 13.93%	56,377 $276,000
Q3 2021 Nov 15, 2021	BUY	$11.15 - $18.6 $540,016 - $900,835	48,432 Added 283.73%	65,502 $829,000
Q2 2021 Aug 16, 2021	BUY	$15.4 - $31.46 $262,878 - $537,022	17,070 New	17,070 $264,000

19.1M

Ticker BOLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,641,500
Market Cap $18.8M
Description
Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.